Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.
The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
Biomimetics Pty Ltd has developed an innovative enabling technology to coat bone-like nanohydroxyapatite for the production of an unique synthetic bone graft material that has increased superiority in bioactivity, strength controlled solubility and drug delivery over similiar products already in the market. It is a platform technology with a wide range of applications.
A bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level.
Bioni's core business is the development, production and marketing of coatings to enhance the walls, facades and roofs of all manner of buildings. Based upon the latest scientific findings in nanotechnology and together with the researchers at the Fraunhofer Institute for Chemical Technology, Bioni has developed an effective nano-filler combination, which when used in both interior and facade paints, permanently prevents the formation of mould, bacteria and algae.
The company's technology is based on the large scale production of nanometric particles known as VLPs (virus like particles). The most advanced application of this technology is the production of viral vector derived vaccines for human and animal health.
The company develops skin care products with its proprietary nanotechnological platform based on the development of Bioactive Complex Modeling (NANO-COMPLEXES™) that has the ability to control nano- and pico- quantities of biologically active substances.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.
Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).
The company has a polymer micro-system technology platform comprising core intellectual property in the areas of polymer multilevel micro- and nano-replication, plastic micro-fluidic chip fabrication and photonics integration, to provide unique products for point-of-use analytical applications.
BioSolar, Inc. has developed a breakthrough technology to produce bio-based materials from renewable plant sources. Through the advanced manipulation of bio-based polymers, BioSolar intends to produce robust bio-based components that meet the stringent thermal and durability requirements of current solar cell manufacturing processes.
Blend Therapeutics is a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases. The company is pioneering an integrative way to discover molecular entities with new mechanisms of action purposely designed for our proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together they can make medicines more targeted, more effective and more tolerable.
Bloo Solar is developing and manufacturing revolutionary nano-structured ultra thin film solar PV products that will provide affordable clean renewable energy for everyone. Bloo's unique technology absorbs and converts more sunlight throughout the day, resulting in a dramatic increase in total power output.
Evolved from more than 15 years research at Sydney's Macquarie University, BluGlass has invented a novel process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN), crucial to the production of high efficiency devices including next generation lighting technology Light Emitting Diodes (LEDs) at a fraction of the current cost.